Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ryan Moslin

5PUBLICATIONS
15CO-AUTHORS
Basic pharmacologyAutoimmunityBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Nov 19, 2024
Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing Agent.

Murugaiah A M Subbaiah, Thangeswaran Ramar, Maheswara Reddy

|Jul 26, 2019
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain.

James R Burke, Lihong Cheng, Kathleen M Gillooly

|Jul 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.

Stephen T Wrobleski, Ryan Moslin, Shuqun Lin

|Jul 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2).

Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski

|Aug 16, 2018
Identification of imidazo[1,2-<i>b</i>]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling.

R Moslin, D Gardner, J Santella

Pageof 1

Frequent Collaborators

3 joint publications

Stephen T Wrobleski

2 joint publications

Percy H Carter

2 joint publications

Steven Spergel

1 joint publications

James R Burke

1 joint publications

Adriana Zupa-Fernandez

1 joint publications

Ian M Catlett

1 joint publications

Elizabeth M Heimrich

1 joint publications

Kim W McIntyre

1 joint publications

Mark D Cunningham

1 joint publications

Murugaiah A M Subbaiah

Frequent Collaborators

3 joint publications

Stephen T Wrobleski

2 joint publications

Percy H Carter

2 joint publications

Steven Spergel

1 joint publications

James R Burke

Top Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on : Aug 02, 2016

14.9K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on : Dec 17, 2010

11.9K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
See more related videos

Top Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on : Aug 02, 2016

14.9K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on : Dec 17, 2010

11.9K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
See more related videos